These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23962263)

  • 41. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment monitoring of topical ingenol mebutate in actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy: a case series.
    Maier T; Cekovic D; Ruzicka T; Sattler EC; Berking C
    Br J Dermatol; 2015 Mar; 172(3):816-8. PubMed ID: 25070046
    [No Abstract]   [Full Text] [Related]  

  • 43. Reduced number of actinic keratoses with topical application of DNA repair enzyme creams.
    DeBoyes T; Kouba D; Ozog D; Fincher E; Moy L; Iwata K; Moy R
    J Drugs Dermatol; 2010 Dec; 9(12):1519-21. PubMed ID: 21120260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75%.
    Stockfleth E; Gupta G; Peris K; Aractingi S; Dakovic R; Alomar A
    Eur J Dermatol; 2014; 24(1):23-7. PubMed ID: 24589500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment.
    Kopasker D; Kwiatkowski A; Matin RN; Harwood CA; Ismail F; Lear JT; Thomson J; Hasan Z; Wali GN; Milligan A; Crawford L; Ahmed I; Duffy H; Proby CM; Allanson PF
    Br J Dermatol; 2019 Apr; 180(4):902-909. PubMed ID: 29782648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
    Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
    Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
    [No Abstract]   [Full Text] [Related]  

  • 49. End points in dermatologic clinical trials: A review for clinicians.
    Wei EX; Kirsner RS; Eaglstein WH
    J Am Acad Dermatol; 2016 Jul; 75(1):203-9. PubMed ID: 26936300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The more the better? An appraisal of combination therapies for actinic keratosis.
    Steeb T; Wessely A; Leiter U; French LE; Berking C; Heppt MV
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):727-732. PubMed ID: 31587385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
    Blauvelt A; Kempers S; Lain E; Schlesinger T; Tyring S; Forman S; Ablon G; Martin G; Wang H; Cutler DL; Fang J; Kwan MR;
    N Engl J Med; 2021 Feb; 384(6):512-520. PubMed ID: 33567191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-reported adherence and persistence to topical treatments for actinic keratosis: a longitudinal diary study.
    Erntoft S; Norlin JM; Pollard C; Diepgen TL
    Br J Dermatol; 2016 Nov; 175(5):1094-1096. PubMed ID: 27088541
    [No Abstract]   [Full Text] [Related]  

  • 54. Focused update: Guidelines of care for the management of actinic keratosis.
    Eisen DB; Dellavalle RP; Frazer-Green L; Schlesinger TE; Shive M; Wu PA
    J Am Acad Dermatol; 2022 Aug; 87(2):373-374.e5. PubMed ID: 35439607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of actinic keratosis for the nurse practitioner: diagnosis, treatment, and clinical pearls.
    Englert C; Hughes B
    J Am Acad Nurse Pract; 2012 May; 24(5):290-6. PubMed ID: 22551333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
    Nguyen HP; Rivers JK
    Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combination of oral and topical photoprotection with a standardized Polypodium leucotomos extract is beneficial against actinic keratosis.
    Pellacani G; Peris K; Ciardo S; Pezzini C; Tambone S; Farnetani F; Longo C; Chello C; González S
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):384-391. PubMed ID: 36892441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensified inflammatory reaction of actinic keratoses after single application of topical 5-fluorouracil in a patient treated with nilotinib for chronic myeloid leukemia.
    Schmid-Wendtner MH; Wendtner CM
    Dermatology; 2009; 219(4):341-3. PubMed ID: 19468201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.
    Huyke C; Reuter J; Rödig M; Kersten A; Laszczyk M; Scheffler A; Nashan D; Schempp C
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.